Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Bio-Rad Laboratories, Inc. (BIO - Free Report) is a manufacturer and supplier of products and systems to separate complex chemical and biological materials. The Zacks Consensus Estimate for its current year earnings has been revised 5.6% downward over the last 30 days.
Coca-Cola FEMSA, S.A.B. de C.V. (KOF - Free Report) is a global beverage company. The Zacks Consensus Estimate for its current year earnings has been revised 2.8% downward over the last 30 days.
Cerner Corporation is a designer, developer and marketer of health care information technology and health care devices. The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 30 days.
Loews Corporation (L - Free Report) is a provider of commercial property and casualty insurance products. The Zacks Consensus Estimate for its current year earnings has been revised 27.9% downward over the last 30 days.
Integer Holdings Corporation (ITGR - Free Report) is a global medical device outsource manufacturer. The Zacks Consensus Estimate for its current year earnings has been revised 2.9% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Bio-Rad Laboratories, Inc. (BIO - Free Report) is a manufacturer and supplier of products and systems to separate complex chemical and biological materials. The Zacks Consensus Estimate for its current year earnings has been revised 5.6% downward over the last 30 days.
Coca-Cola FEMSA, S.A.B. de C.V. (KOF - Free Report) is a global beverage company. The Zacks Consensus Estimate for its current year earnings has been revised 2.8% downward over the last 30 days.
Cerner Corporation is a designer, developer and marketer of health care information technology and health care devices. The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 30 days.
Loews Corporation (L - Free Report) is a provider of commercial property and casualty insurance products. The Zacks Consensus Estimate for its current year earnings has been revised 27.9% downward over the last 30 days.
Integer Holdings Corporation (ITGR - Free Report) is a global medical device outsource manufacturer. The Zacks Consensus Estimate for its current year earnings has been revised 2.9% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on L - FREE
Get the latest research report on BIO - FREE
Get the latest research report on KOF - FREE
Get the latest research report on ITGR - FREE